Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Mimedx Group (MDXG) EBT: 2011-2024

Historic EBT for Mimedx Group (MDXG) over the last 14 years, with Dec 2024 value amounting to $57.3 million.

  • Mimedx Group's EBT rose 100.10% to $22.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $55.7 million, marking a year-over-year decrease of 7.07%. This contributed to the annual value of $57.3 million for FY2024, which is 87.03% up from last year.
  • Per Mimedx Group's latest filing, its EBT stood at $57.3 million for FY2024, which was up 87.03% from $30.6 million recorded in FY2023.
  • In the past 5 years, Mimedx Group's EBT ranged from a high of $57.3 million in FY2024 and a low of -$61.5 million during FY2020.
  • Over the past 3 years, Mimedx Group's median EBT value was $30.6 million (recorded in 2023), while the average stood at $22.7 million.
  • As far as peak fluctuations go, Mimedx Group's EBT tumbled by 140.54% in 2020, and later spiked by 255.13% in 2023.
  • Over the past 5 years, Mimedx Group's EBT (Yearly) stood at -$61.5 million in 2020, then skyrocketed by 80.41% to -$12.1 million in 2021, then plummeted by 63.82% to -$19.7 million in 2022, then skyrocketed by 255.13% to $30.6 million in 2023, then surged by 87.03% to $57.3 million in 2024.